Drug Discovery

As the life science industry faces increasing competition—as well as global regulatory and pricing pressures—outsourcing portions or all of manufacturing is becoming increasingly prevalent....

Sponsored by: 3DS Dassault Systemes REGISTER NOW Broadcast Date: February 5, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Antibody-drug conjugates (ADCs) were initially developed to provide a selective targeting...

Sponsor: Sartorius Stedim BiotechIn this GEN webinar, sponsored by Sartorius Stedim Biotech, we will hear how application of modern bottle and flask closure technologies in combination with machine automation can compress a cell expansion process map to bring about a low-risk, streamlined workflow with reduced operating costs.

Eli Lilly will apply Dicerna Pharmaceuticals’ GalXC™ RNA interference (RNAi) technology platform to discover, develop, and commercialize new treatments based on more than 10...

Sponsor: Cisbio VIEW NOW Broadcast Date: May 21, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET While the importance of ligand-receptor binding kinetics on drug action is...

Sponsor: Nanotemper VIEW NOW Broadcast Date: June 13, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Influenza A virus (IAV) utilizes a multivalent binding strategy to the...

Sponsor: Bio-techne VIEW NOW Broadcast Date: June 11, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET The therapeutic antibody market has reached a fever pitch of enthusiasm,...

Sponsor: Solentim REGISTER NOW Broadcast Date: October 3, 2019 Time: 8:00 am PT, 11:00 am ET, 16:00 GMT, 17:00 CET Successful cell line development (CLD) for the production of...

Sponsor: RedShiftBio REGISTER NOW Broadcast Date: September 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET High hydrostatic pressure has been shown to act as a thermodynamic...

Sponsor: CarterraIn this GEN webinar, sponsored by Carterra, we will demonstrate how modern day high-throughput surface plasmon resonance (HT-SPR™) has facilitated a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline to streamline lead selection. This essentially combines screening and detailed characterization in the same step, condensing months of work into days.